This week Mary and Alex speak with Cliff Reed, Founding CEO, and Dennis Watson, VP Business Development, of Travera, a company specializing in new technology enhancing the landscape of late stage cancer treatment.

Listen on our website, www.downthereaware.com/podcast, or wherever you get your podcasts.

Podcast #Spotify #Anchor #research #advocacy #cancer #Travera #genomics #DNA #MIT #FDA #CLIA #LDT #cancerresearch #technology #cancertechnology #innovation #groundbreaking #latestagecancer #stage4cancer #uterinecancer #ovariancancer #leukemia

Stay Connected

Email Us: downthereaware@gmail.com

Instagram:@downthereaware

Facebook: Down There Aware

Twitter: @downthereaware

Pinterest: Down There Aware

TikTok: Down There Aware

Episode Links

TRAVERA

Episode Highlights

  • Intro [0:13]
  • Welcome Back! [1:25]
  • Guest introductions [1:44]
  • M.I.T. technology [3:42]
  • Genomics and DNA sequencing [3:58]
  • Limited patients [4:05]
  • New measurement tool [4:48]
  • MIT/Dana Farber Cancer Institute partnership [5:32]
  • Infectious disease comparison [5:48]
  • Multiple Myeloma [6:38]
  • “Cheat code” [7:30]
  • Commercial launch [9:09]
  • Test offered for free [10:15]
  • Working with physicians [10:55]
  • Trial and error process for patient [13:20]
  • Advocacy groups [15:25]
  • Patient profile [16:01]
  • Cancer mutation [17:57]
  • Access to live cancer cells [18:38]
  • Quick turn-around for results[21:30]
  • No additional burden on patient [23:35]
  • Early stage testing and limited data [24:28]
  • Predictive accuracy over 80% [25:12]
  • Late stage cancer patients [26:25]
  • Response from oncology community [28:00]
  • Difference in this x vivo test [29:25}
  • No financial risk [30:00]
  • Great value to research and future patients [31:57]
  • MIT intent [34:57]
  • Great creative minds in scientific research [36:15]
  • Future of Travera’s efforts [36:55]
  • The bigger plan [39:01]
  • FDA approval/CLIA certification [40:05]
  • Laboratory Developed Test (LDT) [40:21]
  • Potential to greatly benefit newly diagnosed patients[41:49]
  • Microchip specs [43:45]
  • Physics vs biochemistry[46:20]
  • Simple comparison to a diving board [47:05]
  • Speed and logic [49:47]
  • If someone is listening today and is interested [51:30]
  • dwatson@travera.com [52:23]
  • PHI and HIPAA [53:35]

  • Hearing from those who know best [55:03]

  • Thanks for listening! [56:19]

Stay Connected

Podcast, Spotify, Anchor, research, advocacy, cancer, Travera, genomics, DNA, MIT, FDA, CLIA, LDT, cancer research, technology, cancer technology, innovation, groundbreaking, late-stage cancer, stage 4 cancer, uterine cancer, ovarian cancer, leukemia

Send in a voice message: https://podcasters.spotify.com/pod/show/downthereaware/message

See All 127 Episodes of "Down There Aware"